Loss of CLCA2 expression has been reported to be associated with poor clinical outcomes in patients with breast cancer [28]; however, the impact of reduced expression of CLCA2 on the survival in patients with other types of cancer has not yet been reported. The gene discussed is CLCA2; the disease is breast carcinoma.